Protalix Biotherapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Protalix Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protalix Biotherapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Protalix Biotherapeutics by Citigroup
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $21k | 12k | 1.79 |
2023-09-30 | $3.2k | 1.9k | 1.67 |